Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial

Abstract Poly (ADP-ribose) polymerase inhibitors (PARPi) exploit DNA repair deficiency in germline BRCA1 and BRCA2 pathogenic variant (gBRCAm) cancers. Haematological toxicity limits chemotherapy-PARPi treatment combinations. In preclinical models we identified a schedule combining olaparib and carb...

Full description

Bibliographic Details
Published in:	Nature Communications
Main Authors:	Jean E. Abraham, Lenka Oplustil O’Connor, Louise Grybowicz, Karen Pinilla Alba, Alimu Dayimu, Nikolaos Demiris, Caron Harvey, Lynsey M. Drewett, Rebecca Lucey, Alexander Fulton, Anne N. Roberts, Joanna R. Worley, Ms Anita Chhabra, Wendi Qian, Jessica Brown, Richard Hardy, Anne-Laure Vallier, Steve Chan, Maria Esther Una Cidon, Elizabeth Sherwin, Amitabha Chakrabarti, Claire Sadler, Jen Barnes, Mojca Persic, Sarah Smith, Sanjay Raj, Annabel Borley, Jeremy P. Braybrooke, Emma Staples, Lucy C. Scott, Cheryl A. Palmer, Margaret Moody, Mark J. Churn, Domenic Pilger, Guido Zagnoli-Vieira, Paul W. G. Wijnhoven, Mukesh B. Mukesh, Rebecca R. Roylance, Philip C. Schouten, Nicola C. Levitt, Karen McAdam, Anne C. Armstrong, Ellen R. Copson, Emma McMurtry, Susan Galbraith, Marc Tischkowitz, Elena Provenzano, Mark J. O’Connor, Helena M. Earl, PARTNER Trial Group
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-05-01
Online Access:	https://doi.org/10.1038/s41467-025-59151-0

Similar Items

Prostate screening uptake in Australian <it>BRCA1 </it>and <it>BRCA2 </it>carriers
by: McKinley Joanne M, et al.
Published: (2007-09-01)

Telomere length shows no association with BRCA1 and BRCA2 mutation status.
by: Emma Killick, et al.
Published: (2014-01-01)

Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
by: Pankaja Umarane, et al.
Published: (2023-03-01)

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium
by: Karin Kast, et al.
Published: (2023-06-01)

Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers
by: Alan D McCrorie, et al.
Published: (2020-04-01)

Different Mechanisms in Doxorubicin-Induced Cardiomyopathy: Impact of BRCA1 and BRCA2 Mutations
by: Hien C. Nguyen, et al.
Published: (2024-01-01)

Classifications within molecular subtypes enables identification of BRCA1/BRCA2 mutation carriers by RNA tumor profiling.
by: Martin J Larsen, et al.
Published: (2013-01-01)

Preimplantation Genetic Diagnosis for Brca1 and Brca2 Mutations
by: Yavuz Emre Șükür, et al.
Published: (2016-08-01)

Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness
by: Lars v. B. Andersen, et al.
Published: (2023-06-01)

Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily
by: Stella S, et al.
Published: (2022-04-01)

Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer Patients
by: Abimbola F. Onyia MSc, et al.
Published: (2025-04-01)

Is no news good news? Inconclusive genetic test results in <it>BRCA1 </it>and <it>BRCA2 </it>from patients and professionals' perspectives
by: Ardern-Jones Audrey, et al.
Published: (2010-01-01)

Beyond breast and ovarian cancers: PARP inhibitors for BRCA mutation-associated and BRCA-like solid tumors
by: Ciara C. O'Sullivan, et al.
Published: (2014-02-01)

LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER
by: M. M. Tsyganov, et al.
Published: (2020-07-01)

Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients
by: A. A. Kashintsev, et al.
Published: (2016-02-01)

Genetic Variation of The BRCA1 and BRCA2 Genes in Macedonian Patients
by: Plaseska-Karanfilska Dijana, et al.
Published: (2012-12-01)

Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
by: Ilirjana Bajrami, et al.
Published: (2021-11-01)

Diagnostic Screening Workflow for Mutations in the BRCA1 and BRCA2 Genes
by: Stella Lai, et al.
Published: (2015-01-01)

Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studies
by: Isaac Allen, et al.
Published: (2026-06-01)

Prevalence of Somatic BRCA1 and BRCA2 Mutations in Ovarian Cancer among Filipinos using Next Generation Sequencing
by: Charles Joseph Bernardo, et al.
Published: (2023-05-01)

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
by: Osman K., et al.
Published: (2022-12-01)

Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance.
by: Meryem Ozgencil, et al.
Published: (2021-01-01)

Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing
by: Hyunseok P. Kang, et al.
Published: (2016-06-01)

BRCA1 and BRCA2 Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina
by: Angela R. Solano, et al.
Published: (2018-08-01)

Contribution of germline <it>BRCA1 </it>and <it>BRCA2 </it>sequence alterations to breast cancer in Northern India
by: Sharma Veena K, et al.
Published: (2006-10-01)

Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil
by: V.F. Esteves, et al.
Published: (2009-05-01)

Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies
by: Yonina R. Murciano-Goroff, et al.
Published: (2022-11-01)

Sister chromatid exchanges induced by perturbed replication can form independently of BRCA1, BRCA2 and RAD51
by: Anne Margriet Heijink, et al.
Published: (2022-11-01)

Experience in treating BRCA-associated breast cancer. The BRCA-history of a family
by: A. V. Sultanbaev, et al.
Published: (2021-08-01)

Federated analysis of BRCA1 and BRCA2 variation in a Japanese cohort
by: James Casaletto, et al.
Published: (2022-03-01)

Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations
by: Avantika Lal, et al.
Published: (2019-06-01)

BRCA1 and BRCA2mutations in breast cancer patients from Venezuela
by: Karlena Lara, et al.
Published: (2012-01-01)

Laboratory Verification of a BRCA1 and BRCA2 Massively Parallel Sequencing Assay from Wet Bench to Bioinformatics for Germline DNA Analysis
by: Kok-Siong Poon, et al.
Published: (2021-03-01)

Male with an apparently normal phenotype carrying a BRCA1 exon 20 duplication in trans to a BRCA1 frameshift variant
by: Ines Block, et al.
Published: (2024-01-01)

BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity
by: Eliana MC Tacconi, et al.
Published: (2017-07-01)

BRCA1, BRCA2 mutations — future of predictive oncology: a review of literature
by: V. N. Dmitriev, et al.
Published: (2014-07-01)

The Study of BRCA1 and BRCA2 Gene Mutations in Benign and Malignant Lesions of the Breast
by: Ekundina Victor Olukayode , Unuigbokhai Ayomide Olohigbe , Wilson Serbia Princess
Published: (2023-06-01)

BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
by: Yinmei Zhang, et al.
Published: (2024-01-01)

The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations
by: Steven A. Narod, et al.
Published: (2024-05-01)

Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer
by: Mohammad Hassan Tajadini, et al.
Published: (2013-02-01)